Asian Growth Stocks With Insider Ownership Boasting 120% Earnings Growth

Simply Wall St

Tue, February 17, 2026 at 7:45 AM GMT+9 4 min read

In this article:

8299.TWO

+1.64%

301489

4592

688206

002384.SZ

+0.78%

As global markets navigate the complexities of AI disruption and economic uncertainties, Asian equities present a compelling landscape for growth-oriented investors. In this environment, companies with substantial insider ownership and robust earnings growth stand out as potentially strong candidates for those looking to align with management interests and capitalize on promising financial trajectories.

Top 10 Growth Companies With High Insider Ownership In Asia

Click here to see the full list of 561 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

We’re going to check out a few of the best picks from our screener tool.

Primarius Technologies

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Primarius Technologies Co., Ltd. is engaged in researching, designing, and developing electronic design automation (EDA) tools both in China and internationally, with a market cap of CN¥16.45 billion.

Operations: The company’s revenue primarily comes from its EDA Solutions segment, which generated CN¥454.55 million.

Insider Ownership: 16.1%

Earnings Growth Forecast: 121% p.a.

Primarius Technologies, a growth-oriented company in Asia, is forecast to experience substantial earnings growth of 121% annually over the next three years, surpassing the Chinese market average. However, its revenue growth is expected to be slightly below 20%. Recently profitable, Primarius has seen Shanghai S&T Venture Capital acquire a 5% stake for approximately CNY 690 million. Despite strong earnings projections, its future return on equity remains low at an estimated 3.4%.

Click to explore a detailed breakdown of our findings in Primarius Technologies' earnings growth report.

In light of our recent valuation report, it seems possible that Primarius Technologies is trading beyond its estimated value.

SHSE:688206 Earnings and Revenue Growth as at Feb 2026

GuangDong Suqun New MaterialLtd

Simply Wall St Growth Rating: ★★★★★☆

Overview: GuangDong Suqun New Material Co., Ltd. focuses on the R&D, production, and sales of electronic and electrical functional materials in China, with a market cap of CN¥14.31 billion.

Story Continues  

Operations: GuangDong Suqun New Material Co., Ltd. generates revenue through its involvement in the research, development, production, and sales of electronic and electrical functional materials within China.

Insider Ownership: 33.9%

Earnings Growth Forecast: 44% p.a.

GuangDong Suqun New Material Ltd. is poised for robust growth with earnings expected to increase significantly by 44% annually, outpacing the Chinese market average of 28.2%. Revenue is projected to grow at 25.9% per year, surpassing the market’s 14.9% forecast. Despite these positive growth indicators, the company’s return on equity is anticipated to be relatively low at 14.3% in three years, and its share price has been highly volatile recently.

Delve into the full analysis future growth report here for a deeper understanding of GuangDong Suqun New MaterialLtd.

The analysis detailed in our GuangDong Suqun New MaterialLtd valuation report hints at an inflated share price compared to its estimated value.

SZSE:301489 Earnings and Revenue Growth as at Feb 2026

SanBio

Simply Wall St Growth Rating: ★★★★★★

Overview: SanBio Company Limited focuses on developing, producing, and selling regenerative cell medicines for the central nervous system with a market cap of ¥176.04 billion.

Operations: SanBio Company Limited’s revenue is derived from its activities in developing, producing, and selling regenerative cell medicines targeting the central nervous system.

Insider Ownership: 24.9%

Earnings Growth Forecast: 43.4% p.a.

SanBio is set for significant growth, with revenue expected to increase by 42.2% annually, surpassing the Japanese market average. Earnings are projected to grow at 43.41% per year, and the company is anticipated to become profitable within three years. Despite its volatile share price recently, SanBio’s innovative AKUUGO treatment has received approval changes from Japan’s Ministry of Health, potentially enhancing its market position in regenerative brain therapies while insider trading activity remains stable.

Click here and access our complete growth analysis report to understand the dynamics of SanBio.

According our valuation report, there's an indication that SanBio's share price might be on the expensive side.

TSE:4592 Ownership Breakdown as at Feb 2026

Next Steps

Get an in-depth perspective on all 561 Fast Growing Asian Companies With High Insider Ownership by using our screener here.

Ready To Venture Into Other Investment Styles? Trump has pledged to "unleash" American oil and gas and these 21 US stocks have developments that are poised to benefit.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years._

Companies discussed in this article include SHSE:688206 SZSE:301489 and TSE:4592.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info